N

NewLimit

Develops epigenetic medicines to extend healthspan

Scientist - Delivery Sciences - Targeted LNPs - Targeted LNPs

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USAIn-person

About the Job

Requirements

  • A PhD in Pharmaceutical Sciences, Pharmaceutical Chemistry, Biochemistry, or a related discipline, plus 1–2 years of relevant work; or an MS with 5 years of focused tLNP design experience for liposomal or lipid nanoparticle applications.
  • Strong skill in personally designing and formulating new targeted LNPs without a supervisor directing each step.
  • Experience with SAR-driven design, purification, and characterization of tLNPs and targeted-moiety-conjugated lipids, and AI-based SAR prediction tools for tLNP applications.
  • Working knowledge of conjugation chemistries for attaching targeting moieties such as peptides, antibodies, nanobodies, and small-molecule ligands, including linker design and selecting suitable biorthogonal or site-specific handles.
  • Practical purification skills spanning normal- and reverse-phase chromatography, size-exclusion chromatography, and preparative HPLC.
  • Analytical characterization experience across LC-CAD, LC-UV, DLS, CE, bio-layer interferometry, and surface plasmon resonance, with the ability to interpret the data to produce well-characterized tLNPs.

Responsibilities

  • Design and develop LNP compositions and conjugation chemistries for antibodies, nanobodies, scFvs, peptides, and other targeting moieties across multiple structural families to advance extra-hepatic targeting.
  • Plan conjugation reactions and purification with scale and final purity in mind, and deliver against agreed project timelines.
  • Test targeting lipids for the tLNP platform using an SAR-based approach to guide the next design cycle.
  • Develop conjugation chemistries in-house or work with external partners to obtain targeted LNPs for particular target cells, and build processes that support research teams in testing tLNPs in vivo.
  • Translate in vitro and in vivo discovery data into structural hypotheses and optimize tLNP compositions or targeting molecules.
  • Present experimental results and SAR conclusions, and author protocols and technical reports.

Desired Qualifications

  • Familiarity with novel conjugation chemistries and reaction methods.
  • Experience optimizing targeting moieties for immune cells and endothelial cells.
  • Exposure to scale-up process development, CMC, or technology transfer to a CDMO.
  • Experience with data visualization and statistical analysis using R, Python, or JMP.

About the Company

NewLimit

Develops epigenetic medicines to extend healthspan

NewLimit develops medicines that aim to extend healthy years by reprogramming the epigenome of aging cells. It works by identifying aging-related epigenetic changes using single-cell genomics, machine learning, and high-throughput functional assays, then creating interventions to reverse those changes in targeted tissues such as the immune system and liver. Compared with others, NewLimit combines a specific focus on epigenetic reprogramming with a data-driven, tissue-targeted pipeline and pursues partnerships with pharma and biotech players to develop its proprietary medicines. Its goal is to deliver a new class of medicines that significantly increases the healthspan for patients with age-related diseases.

Company size
51-200
Company stage
Series C
Total funding
$650M
Headquarters
South San Francisco, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at NewLimit

See more jobs